Biotech RadarJobs updated

COMPANY

Sensydia

HQ: Valencia, CA source · sensydia.com ↗

FDA-cleared device company

Keywords: cardiovascular Cardiac Disease Cardiovascular Diseases Cardiac Performance System (NSR) Cardiac Performance System

Location: Valencia, CA · source · Oct 12, 2026

Profile checked Oct 10, 2026

4Trials (company is sponsor)

Funding and NIH signals

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

Raises announced in these releases: $6M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Raise Undisclosed round · more than $6M source ↗
  2. Grant Government grant — STTR: $816,106 (annual award, as published), announced May 13, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
  3. Trial start —: Pivotal Study for the Cardiac Performance System (CPS) source ↗
  4. Grant Government grant — STTR: $1.61M (annual award, as published), announced Apr 16, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
  5. Trial start —: Cardiac Performance System Data Collection Study - Minnesota source ↗
  6. Trial start —: Cardiac Performance System Data Collection Study source ↗
  7. Trial start —: Cardiac Function Non-Invasive Monitoring System Evaluation Trial source ↗

Funding

Last 2 years.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT06870591Pivotal Study for the Cardiac Performance System (CPS)Not listedRecruitingApr 22, 2025Apr 30, 2026 (estimated)
NCT06149143Cardiac Performance System Data Collection Study - MinnesotaNot listedUnknown status (ClinicalTrials.gov)Oct 3, 2023Jun 30, 2024 (estimated)
NCT04131725Cardiac Function Non-Invasive Monitoring System Evaluation TrialNot listedCompletedNov 9, 2020Feb 1, 2023 (actual)
NCT05866666Cardiac Performance System Data Collection StudyNot listedUnknown status (ClinicalTrials.gov)May 30, 2023May 31, 2024 (estimated)
Feedback